A new trading day began on Tuesday, with Viking Therapeutics Inc (NASDAQ: VKTX) stock price up 0.50% from the previous day of trading, before settling in for the closing price of $31.94. VKTX’s price has ranged from $18.92 to $81.73 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -23.00%. Meanwhile, its annual earnings per share averaged -86.96%. With a float of $108.96 million, this company’s outstanding shares have now reached $112.29 million.
Let’s determine the extent of company efficiency that accounts for 36 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Viking Therapeutics Inc (VKTX) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Viking Therapeutics Inc is 2.98%, while institutional ownership is 69.41%. The most recent insider transaction that took place on Jul 03 ’25, was worth 747,633. In this transaction President & CEO of this company sold 26,889 shares at a rate of $27.80, taking the stock ownership to the 2,388,014 shares. Before that another transaction happened on Jul 03 ’25, when Company’s Chief Financial Officer sold 4,266 for $27.76, making the entire transaction worth $118,428. This insider now owns 168,660 shares in total.
Viking Therapeutics Inc (VKTX) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -86.96% per share during the next fiscal year.
Viking Therapeutics Inc (NASDAQ: VKTX) Trading Performance Indicators
Here are Viking Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 44.25.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.15, a number that is poised to hit -0.45 in the next quarter and is forecasted to reach -2.57 in one year’s time.
Technical Analysis of Viking Therapeutics Inc (VKTX)
Looking closely at Viking Therapeutics Inc (NASDAQ: VKTX), its last 5-days average volume was 3.14 million, which is a drop from its year-to-date volume of 4.07 million. As of the previous 9 days, the stock’s Stochastic %D was 65.53%.
During the past 100 days, Viking Therapeutics Inc’s (VKTX) raw stochastic average was set at 89.72%, which indicates a significant increase from 78.51% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.53 in the past 14 days, which was lower than the 1.73 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $28.18, while its 200-day Moving Average is $37.85. However, in the short run, Viking Therapeutics Inc’s stock first resistance to watch stands at $32.58. Second resistance stands at $33.07. The third major resistance level sits at $33.54. If the price goes on to break the first support level at $31.62, it is likely to go to the next support level at $31.15. Should the price break the second support level, the third support level stands at $30.66.
Viking Therapeutics Inc (NASDAQ: VKTX) Key Stats
With a market capitalization of 3.61 billion, the company has a total of 112,310K Shares Outstanding. Currently, annual sales are 0 K while annual income is -109,960 K. The company’s previous quarter sales were 0 K while its latest quarter income was -45,630 K.
